
    
      This is a prospective, randomized, double-blind controlled clinical trial. Written informed
      consent will be obtained from patients. Patients will be randomly assigned using the sealed
      envelope technique into 2 equal groups: Group 1 will be patients who receive general
      anesthesia with paravertebral block, whereas group 2 will be patients who receive general
      anesthesia with placebo block.
    
  